tirzepatide in a vial | GLP1 | Medical Weight Loss Eli Lilly Launches Self-Pay Vials

Among the marketed large molecule injectable GLP-1 agonists, semaglutide, apart from weight-loss, is being studied for kidney disease and tirzepatide (a dual GLP-1 and GIP receptor agonist) is being evaluated for sleep apnea in Ph 3 clinical trials

Practical guidance on safe prescribing, protein, bone support, and exercise tailored for older adults considering GLP-1 therapy.

Novo Nordisks semaglutidemarketed under the names Wegovy and Ozempichave already shown their potential to treat diabetes, obesity, cardiovascular (CV) conditions and maybe even reduce aging, too.

Targeting glutamine transporters and downstream enzymes involved in glutamine metabolism holds significant promise in enhancing anti-tumor immunity

Weight loss drugs like Ozempic and Wegovy may provide strong relief from severe osteoarthritis knee pain, new research finds.

L-Theanine & Lemon Balm is a combination of an active amino acid, paired in this formulation with lemon balm extract